A John Camm

A John Camm

Professor of Clinical Cardiology

PhD

Imperial College London, London, UK

  • LinkedIn
  • X
  • Radcliffe
  • OrcidID

Biography

A. John Camm is a British cardiologist internationally recognised for his contributions to clinical cardiology and cardiac electrophysiology. He has spent the majority of his professional career in the United Kingdom and has been closely associated with St George’s, University of London, where he has lived and worked for many decades. Throughout his career, he has combined clinical practice, academic leadership, and international guideline development, becoming one of the most influential figures in modern arrhythmia management.

 

Academic History

Professor Camm undertook his medical education and postgraduate training in the United Kingdom, progressing through specialist training in internal medicine and cardiology before focusing on cardiac electrophysiology. He developed a strong academic foundation early in his career, which led to senior academic appointments in cardiovascular medicine.

He was appointed British Heart Foundation Professor of Clinical Cardiology at St George’s, University of London, a role he held for many years before becoming Emeritus Professor. His academic work has consistently focused on translational and clinical research, bridging basic electrophysiological mechanisms with patient-centred cardiovascular care.

 

Career Overview

Professor Camm has had a distinguished career as a clinician-scientist, academic leader, and educator. At St George’s, University of London, he played a central role in shaping the cardiology and electrophysiology programmes, mentoring generations of cardiologists and researchers. His clinical interests have centred on cardiac arrhythmias, atrial fibrillation, stroke prevention, and the safe and effective use of anticoagulation therapies.

He has been deeply involved in medical publishing and scholarly communication. Professor Camm is Editor of the European Society of Cardiology (ESC) Textbook of Cardiovascular Medicine and ESC CardioMed, and has overseen major sections covering electrophysiology, clinical cardiology, and evidence-based cardiology. Over the course of his career, he has written or edited more than 40 textbooks, primarily in the field of cardiac arrhythmology.

His research output is exceptional, with authorship or co-authorship of more than 1,450 peer-reviewed scientific papers, over 500 book chapters, and more than 2,500 accepted scientific abstracts. He has also delivered in excess of 1,000 invited international lectures, reflecting his standing as a global authority in cardiology.

Professor Camm has played a pivotal role in the development of international clinical practice guidelines. Most notably, he has been extensively involved in the production of ESC guidelines for the management of atrial fibrillation, which have shaped clinical practice worldwide. In addition, he serves on the editorial board of Arrhythmia & Electrophysiology Review, contributing to the advancement of knowledge in heart rhythm disorders.

 

Career Timeline

  • Medical training and postgraduate cardiology specialisation in the United Kingdom
  • Appointment to senior academic and clinical roles at St George’s, University of London
  • Named British Heart Foundation Professor of Clinical Cardiology, St George’s, University of London
  • Editor of ESC Textbook of Cardiovascular Medicine and ESC CardioMed
  • Lead contributor to multiple ESC guidelines, including atrial fibrillation management
  • Transition to Emeritus Professor status while remaining active in research, publishing, and education

 

Recognition

Professor Camm is widely regarded as one of the leading authorities in cardiac arrhythmias and atrial fibrillation. His work has influenced clinical guidelines, regulatory decisions, and everyday cardiology practice across Europe and internationally. He is frequently invited to speak at major global cardiology congresses and has received sustained recognition for his academic output, editorial leadership, and service to professional societies.

 

Areas of Speciality

  • Cardiac Arrhythmias
  • Atrial Fibrillation
  • Clinical Cardiac Electrophysiology
  • Stroke Prevention in Cardiology
  • Anticoagulation Therapy
  • Evidence-Based Cardiology

 

Sources

Media

Broadcast

LAAC Summit Module 1: Reducing stroke risk & bleed in AF patients

A John Camm, Martin Bergmann, Tim Betts

Broadcast

Presented at EHRA 2021

A John Camm, Hugh Calkins, Claudio Tondo

Watch time: 30m 2s

Broadcast

Improving Efficiency in Stroke Prevention

David Hildick-Smith, Tim Betts, A John Camm

Watch time: 1h 32m 45s

Broadcast

Emerging Evidence in LAA Occlusion vs. NOAC Therapy

Jens Erik Nielsen Kudsk, A John Camm, Vivek Reddy

Watch time: 51m 8s

Articles by A John Camm, Professor of Clinical Cardiology

Letter from the New President of the European Heart Rhythm Association

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(3):107.

Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy

C Fielder Camm, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(2):63–8.

A Clinical Perspective on Sudden Cardiac Death

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2016;5(3):177–82

Anticoagulation in Atrial Fibrillation – Current Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(2):100–7

Early Repolarisation Syndrome – New Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(3):169–71

Inherited Arrhythmias – Where do we Stand?

A John Camm, Bernard J Gersh, Demosthenes G Katritsis, et al

Citation: Arrhythmia & Electrophysiology Review 2014;3(2):80–4

Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions

Katrina Mountfort, A John Camm, Gregory YH Lip, et al

Citation: Arrhythmia & Electrophysiology Review 2014;3(3):194–200

The Role of Continuous Monitoring in Atrial Fibrillation Management

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2014;3(1):48-50

Stroke Prevention in Atrial Fibrillation - The Unmet Need and Morbidity Burden

A John Camm,

Citation: European Cardiology 2011;7(3):187–95

Considerations for the Development of New Antiarrhythmic Drugs

A John Camm, Craig Pratt, Silvia Priori, et al

Citation: European Cardiology 2010;6(2 Suppl):3–7

Epidemiology and Economic Burden of Atrial Fibrillation

A Bajpai, A John Camm, I Savelieva, et al

Citation: US Cardiology 2007;4(1):14–7

Antidotes or Reversibility Agents – Are they Needed?

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):6-7

Once or Twice-daily NOAC Therapy – Theory and Practice

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):5

Keywords

cardiac arrhythmia, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, myocardial infarction, heart failure, cardiomyopathy